Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Indian Journal of Forensic Medicine

Hypoglycemic Effects of Rosa damascena Mill. Ethanolic Extract on Blood Glucose Levels and Diameter of Langerhans Pancreatic Islets Bilqis Inayatillah; Tamam Jauhar; Gondo Mastutik; Alphania Rahniayu
Indian Journal of Forensic Medicine & Toxicology Vol. 15 No. 2 (2021): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v15i2.14679

Abstract

Background: Diabetes mellitus is a chronic disorder caused by elevated levels of high blood glucose(hyperglycemia). This chronic hyperglycemia causes ROS to accumulate and oxidative stress to increase.Rosa damascena is a plant that contains high levels of antioxidants and polyphenols, but this is not widelyknown to the public. Purpose: The aim of this study is to understand the hypoglycemic effects from Rosadamascena on blood glucose levels and diameter of Langerhans pancreatic islets. Method: Thirty Wistaralbino rats (200-225gr) were divided into 6 groups. Group 1 was a normal control (KN), group 2 washyperglycemic (KD), group 3 was metformin 250 mg/kg BW (KM), group 4 was treatment extract 250 mg/kg BW (P1), group 5 was treatment extract 500 mg/kg BW (P2) group 6 was treatment extract 1000 mg/kg BW (P3). All animals in the group were injected with STZ 50 mg/kg BW, except for group 1. Result:Data were analyzed statistically using SPSS- 22 software with the Kruskall-Wallis test (p<0.05). The resultshowed that ethanolic extract of Rosa damascena has decreased blood glucose levels in days-14 (382±21,97) with 250 mg/kg BW (P1) compare with another treatment group. In histological observed there areno significant different between group (p>0.05). This is showing that ethanolic extract of Rosa damascenahas inability to repaired the diameter of Langerhans pancreatic islets. Conclusion: Ethanolic extract of Rosadamascena decreased blood glucose levels but did not repaired the diameter of Langerhans pancreatic islets.
The Correlation of EMMPRIN and EGFR Overexpression toward Muscle Invasiveness in Urothelial Carcinoma of Bladder Leonita Agustin Hambalie; Anny Setijo Rahaju; Gondo Mastutik
Indian Journal of Forensic Medicine & Toxicology Vol. 15 No. 2 (2021): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v15i2.14782

Abstract

Urothelial carcinomas represent 90% of all primary bladder cancers. Muscle invasion is a critical prognosticdeterminant in urothelial carcinoma. The overexpression of EMMPRIN and EGFR was found in urothelialcarcinoma. The association between the two markers has not been reported in urothelial carcinoma,therefore we aimed to analyze the expression of EMMPRIN and EGFR and investigate their association withurothelial carcinoma invasiveness. Paraffin-embedded tissues were obtained from 54 urothelial carcinomapatients which then underwent immunohistochemistry staining for EMMPRIN and EGFR antibody. Thecomparison of EMMPRIN and EGFR expression was tested using the Mann Whitney U test. The correlationwas analyzed using the Spearman test. Results showed a significant difference of EMMPRIN expressionbetween non-muscle-invasive and muscle-invasive bladder cancer (p = 0.000), and EMMPRIN expressionwas significantly correlated with the muscle invasion (rs = 0.481, p = 0.000). A significant difference ofEGFR expression between the non-muscle-invasive and muscle-invasive bladder cancer was also found(p = 0.020), and EGFR expression was significantly correlated with the muscle invasion (rs = 0.319, p =0.019). The expression of EMMPRIN was positively correlated with EGFR in urothelial carcinoma (rs =0.322, p = 0.018). The expression of EMMPRIN and EGFR are two potential biomarkers for urothelialcarcinoma invasiveness which may be helpful to differentiate between muscle-invasive and non-muscleinvasive bladder cancer.
Co-Authors Afria Arista Afria Arista Afria Arista, Afria Agung Dwi Suprayitno Agus Santosa Agus Santosa Ali Rohman Alphania Rahniayu Aniek Meidi, Aniek Anny Setijo Rahaju, Anny Setijo Ariani, Grace Arifa Mustika Aryati , Aryati Aryati Aryati Aryati Aryati Bagus Setyoboedi Benediktus Yohan Bilqis Inayatillah Budi Harjanto Cempaka Harsa Sekarputri Dewi Sartika A. W. Dini Indah Berlianti Dwi Murtiastutik DYAH FAUZIAH, DYAH Erni J. Nelwan, Erni J. Erni Juwita Nelwan, Erni Juwita Faisal Amir Faroek Hoesin Fira Soraya Heriyawati, Heriyawati Heru Fajar Trianto I'tishom, Reny Ilmiah, Khafidhotul Imam Susilo Indiastuti, Danti Nur Iqhrammullah, Muhammad Isnin Anang Marhana Jennifer Susanto Juniastuti Juniastuti Khafidhotul Ilmiah Khafidhotul Ilmiah Kuntaman Kuntaman Kusumastuti , Etty Hary Kusumastuti, Etty Hari KUSUMASTUTI, ETTY HARY Lasmauli Situmorang Leonita Agustin Hambalie Markus Kore Masyeni, Sri Mochamad Amin Mochamad Amin Muchlis AU Sofro Nabiha Missaoui Nila Kurniasari Nila Kurniasari Nurma Yuliyanasari, Nurma Poernomo Boedi Setiawan Purnomo, Windu Qonitatillah, Ana R. Tedjo Sasmono Rahmi Alia Rahmi Alia Rahmi Alia Rahmi Alia, Rahmi Renny I’tishom Ridholia Ridholia, Ridholia Rizki Eko Prasetyo S.Pd. M Kes I Ketut Sudiana . Sari, Aditya Sita Sasmono, R. Tedjo Shaohong Lai Sjahjenny Mustokoweni, Sjahjenny Sjamsul Arief Sofro, Muchlis AU Sofro, Muchlis AU. Sri Masyeni, Dewa Ayu Putri Suhartono Taat Putra Sunaryo Hardjowijoto Sutrisno Sutrisno Tamam Jauhar Trisniartami Setyaningrum Usman Hadi Willy Sandhika Windu Purnomo Wira Santoso Ongko Wiratama, Priangga Adi Yohan, Benediktus Yugi Hari Chandra Purnama